L. H. Sehn Et Al. , "Polatuzumab Vedotin Plus Bendamustine and Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL): Final Results of a Phase Ib/II Randomized Study and Single-Arm Extension (Ext) Study," 64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , Louisiana, United States Of America, pp.9464-9467, 2022
Sehn, L. H. Et Al. 2022. Polatuzumab Vedotin Plus Bendamustine and Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL): Final Results of a Phase Ib/II Randomized Study and Single-Arm Extension (Ext) Study. 64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , (Louisiana, United States Of America), 9464-9467.
Sehn, L. H., Hertzberg, M., Opat, S., Herrera, A. F., Assouline, S., Flowers, C. R., ... Kim, T. M.(2022). Polatuzumab Vedotin Plus Bendamustine and Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL): Final Results of a Phase Ib/II Randomized Study and Single-Arm Extension (Ext) Study . 64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) (pp.9464-9467). Louisiana, United States Of America
Sehn, Laurie Et Al. "Polatuzumab Vedotin Plus Bendamustine and Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL): Final Results of a Phase Ib/II Randomized Study and Single-Arm Extension (Ext) Study," 64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), Louisiana, United States Of America, 2022
Sehn, Laurie H. Et Al. "Polatuzumab Vedotin Plus Bendamustine and Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL): Final Results of a Phase Ib/II Randomized Study and Single-Arm Extension (Ext) Study." 64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , Louisiana, United States Of America, pp.9464-9467, 2022
Sehn, L. H. Et Al. (2022) . "Polatuzumab Vedotin Plus Bendamustine and Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL): Final Results of a Phase Ib/II Randomized Study and Single-Arm Extension (Ext) Study." 64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) , Louisiana, United States Of America, pp.9464-9467.
@conferencepaper{conferencepaper, author={Laurie H. Sehn Et Al. }, title={Polatuzumab Vedotin Plus Bendamustine and Rituximab in Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL): Final Results of a Phase Ib/II Randomized Study and Single-Arm Extension (Ext) Study}, congress name={64th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH)}, city={Louisiana}, country={United States Of America}, year={2022}, pages={9464-9467} }